tradingkey.logo

Tactile Systems Technology Inc

TCMD
27.910USD
+0.700+2.57%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
623.39MMarktkapitalisierung
36.10KGV TTM

Tactile Systems Technology Inc

27.910
+0.700+2.57%

mehr Informationen über Tactile Systems Technology Inc Unternehmen

Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company that manufactures and distributes medical devices for the treatment of patients with chronic diseases at home. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. It markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. It also offers Kylee, a free mobile application that helps patients learn about lymphedema.

Tactile Systems Technology Inc Informationen

BörsenkürzelTCMD
Name des UnternehmensTactile Systems Technology Inc
IPO-datumJul 28, 2016
CEODodd (Sheri L)
Anzahl der mitarbeiter1037
WertpapierartOrdinary Share
GeschäftsjahresendeJul 28
Addresse3701 Wayzata Blvd, Suite 300
StadtMINNEAPOLIS
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl55416
Telefon18333822845
Websitehttps://www.tactilemedical.com/
BörsenkürzelTCMD
IPO-datumJul 28, 2016
CEODodd (Sheri L)

Führungskräfte von Tactile Systems Technology Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Raymond O. (Ray) Huggenberger
Mr. Raymond O. (Ray) Huggenberger
Independent Director
Independent Director
56.32K
+16078.00%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Chairman of the Board
Independent Chairman of the Board
48.52K
+12778.00%
Ms. Carmen B. Volkart
Ms. Carmen B. Volkart
Independent Director
Independent Director
37.70K
+16078.00%
Ms. Elaine M. Birkemeyer
Ms. Elaine M. Birkemeyer
Chief Financial Officer
Chief Financial Officer
24.67K
-2921.00%
Ms. Sheri L. Dodd
Ms. Sheri L. Dodd
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Kristie T. Burns
Ms. Kristie T. Burns
Senior Vice President - Marketing and Clinical Affairs
Senior Vice President - Marketing and Clinical Affairs
--
--
Ms. Valerie L. (Val) Asbury
Ms. Valerie L. (Val) Asbury
Independent Director
Independent Director
--
--
Mr. D. Brent Shafer
Mr. D. Brent Shafer
Independent Director
Independent Director
--
--
Dr. B. Vindell Washington, M.D.
Dr. B. Vindell Washington, M.D.
Independent Director
Independent Director
--
--
Mr. Sam Bentzinger
Mr. Sam Bentzinger
Investor Relations Contact Officer
Investor Relations Contact Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Raymond O. (Ray) Huggenberger
Mr. Raymond O. (Ray) Huggenberger
Independent Director
Independent Director
56.32K
+16078.00%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Chairman of the Board
Independent Chairman of the Board
48.52K
+12778.00%
Ms. Carmen B. Volkart
Ms. Carmen B. Volkart
Independent Director
Independent Director
37.70K
+16078.00%
Ms. Elaine M. Birkemeyer
Ms. Elaine M. Birkemeyer
Chief Financial Officer
Chief Financial Officer
24.67K
-2921.00%
Ms. Sheri L. Dodd
Ms. Sheri L. Dodd
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Kristie T. Burns
Ms. Kristie T. Burns
Senior Vice President - Marketing and Clinical Affairs
Senior Vice President - Marketing and Clinical Affairs
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2023
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Lymphedema products
72.38M
84.40%
Airway clearance products
13.37M
15.60%
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Lymphedema products
72.38M
84.40%
Airway clearance products
13.37M
15.60%

Aktionärsstatistik

Aktualisiert: Sat, Feb 7
Aktualisiert: Sat, Feb 7
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Morgan Stanley & Co. LLC
9.48%
Cadian Capital Management LP
9.20%
The Vanguard Group, Inc.
7.30%
BlackRock Institutional Trust Company, N.A.
7.27%
Paradigm Capital Management, Inc.
6.89%
Andere
59.86%
Aktionäre
Aktionäre
Anteil
Morgan Stanley & Co. LLC
9.48%
Cadian Capital Management LP
9.20%
The Vanguard Group, Inc.
7.30%
BlackRock Institutional Trust Company, N.A.
7.27%
Paradigm Capital Management, Inc.
6.89%
Andere
59.86%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
39.75%
Investment Advisor/Hedge Fund
36.37%
Hedge Fund
13.97%
Research Firm
10.78%
Individual Investor
2.69%
Sovereign Wealth Fund
0.65%
Pension Fund
0.46%
Family Office
0.24%
Bank and Trust
0.12%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
348
22.52M
100.81%
-5.60M
2025Q3
366
22.60M
101.18%
-8.77M
2025Q2
389
24.67M
110.65%
-7.05M
2025Q1
401
24.00M
103.20%
-7.47M

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Morgan Stanley & Co. LLC
2.12M
9.48%
-47.75K
-2.20%
Sep 30, 2025
Cadian Capital Management LP
2.06M
9.2%
-137.06K
-6.25%
Sep 30, 2025
The Vanguard Group, Inc.
1.55M
6.93%
+34.70K
+2.29%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.62M
7.27%
+1.30K
+0.08%
Sep 30, 2025
Paradigm Capital Management, Inc.
1.54M
6.89%
-80.20K
-4.95%
Sep 30, 2025
Nomura Investment Management Business Trust
1.20M
5.39%
--
--
Mar 13, 2025
Dimensional Fund Advisors, L.P.
1.19M
5.33%
+24.00K
+2.06%
Sep 30, 2025
Capitolis Liquid Global Markets LLC
902.06K
4.04%
--
--
Sep 30, 2025
Acadian Asset Management LLC
845.45K
3.79%
+161.79K
+23.66%
Sep 30, 2025
Geode Capital Management, L.L.C.
570.57K
2.55%
-5.07K
-0.88%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Cambria Micro and SmallCap Shareholder Yield ETF
1.13%
Invesco NASDAQ Future Gen 200 ETF
0.61%
First Trust Active Factor Small Cap ETF
0.61%
Lattice Hartford Multifactor Small Cap ETF
0.58%
Federated Hermes MDT Small Cap Core ETF
0.38%
Unusual Whales Subversive Democratic Trading ETF
0.37%
iShares US Small Cap Value Factor ETF
0.33%
Royce Quant Small-Cap Quality Value ETF
0.21%
Vanguard US Multifactor ETF
0.14%
VictoryShares Small Cap Free Cash Flow ETF
0.12%
Mehr Anzeigen
Cambria Micro and SmallCap Shareholder Yield ETF
Anteil1.13%
Invesco NASDAQ Future Gen 200 ETF
Anteil0.61%
First Trust Active Factor Small Cap ETF
Anteil0.61%
Lattice Hartford Multifactor Small Cap ETF
Anteil0.58%
Federated Hermes MDT Small Cap Core ETF
Anteil0.38%
Unusual Whales Subversive Democratic Trading ETF
Anteil0.37%
iShares US Small Cap Value Factor ETF
Anteil0.33%
Royce Quant Small-Cap Quality Value ETF
Anteil0.21%
Vanguard US Multifactor ETF
Anteil0.14%
VictoryShares Small Cap Free Cash Flow ETF
Anteil0.12%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI